PROMITIL Trademark

Trademark Overview

On Thursday, March 29, 2012, a trademark application was filed for PROMITIL with the United States Patent and Trademark Office. The USPTO has given the PROMITIL trademark a serial number of 85583041. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 15, 2023. This trademark is owned by Lipomedix Pharmaceuticals Ltd.. The PROMITIL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, a medicine or drug product consisting of one or more ingredients administered to patients to treat cancer
promitil

General Information

Serial Number85583041
Word MarkPROMITIL
Filing DateThursday, March 29, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 15, 2023
Registration Number4299291
Registration DateTuesday, March 5, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, a medicine or drug product consisting of one or more ingredients administered to patients to treat cancer
Translation of Words in MarkThe wording "PROMITIL" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 15, 2023
Primary Code005
First Use Anywhere DateSunday, July 1, 2012
First Use In Commerce DateSunday, July 1, 2012

Trademark Owner History

Party NameLipomedix Pharmaceuticals Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRamat Hasharon 47445
IL
Party NameLipomedix Pharmaceuticals Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRamat Hasharon 47445
IL
Party NameLipomedix Pharmaceuticals Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRamat Hasharon 47445
IL

Trademark Events

Event DateEvent Description
Friday, September 15, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, March 5, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, November 20, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, November 20, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, November 20, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 14, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 14, 2018TEAS SECTION 8 RECEIVED
Monday, March 5, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 1, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 5, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, January 30, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 29, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, January 23, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 17, 2013STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 20, 2012USE AMENDMENT FILED
Thursday, January 17, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 20, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, December 4, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 9, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2012PUBLISHED FOR OPPOSITION
Wednesday, September 19, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 6, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, September 2, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, August 12, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, August 12, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 2, 2012ASSIGNED TO LIE
Wednesday, July 25, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 17, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 17, 2012NON-FINAL ACTION E-MAILED
Tuesday, July 17, 2012NON-FINAL ACTION WRITTEN
Tuesday, July 10, 2012ASSIGNED TO EXAMINER
Wednesday, April 4, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 2, 2012NEW APPLICATION ENTERED

Related Keywords

promitil administered ingredients patients treat cancer more consisting namely preparations medicine